[go: up one dir, main page]

FI952721L - Aine maksa-sappi-sairauksien hoitamiseksi - Google Patents

Aine maksa-sappi-sairauksien hoitamiseksi Download PDF

Info

Publication number
FI952721L
FI952721L FI952721A FI952721A FI952721L FI 952721 L FI952721 L FI 952721L FI 952721 A FI952721 A FI 952721A FI 952721 A FI952721 A FI 952721A FI 952721 L FI952721 L FI 952721L
Authority
FI
Finland
Prior art keywords
substance
treatment
hepatobiliary diseases
hepatobiliary
diseases
Prior art date
Application number
FI952721A
Other languages
English (en)
Swedish (sv)
Other versions
FI952721A0 (fi
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of FI952721A0 publication Critical patent/FI952721A0/fi
Publication of FI952721L publication Critical patent/FI952721L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952721A 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi FI952721L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12248794 1994-06-03

Publications (2)

Publication Number Publication Date
FI952721A0 FI952721A0 (fi) 1995-06-02
FI952721L true FI952721L (fi) 1995-12-04

Family

ID=14837070

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952721A FI952721L (fi) 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi

Country Status (14)

Country Link
US (1) US5739161A (fi)
EP (1) EP0690049B1 (fi)
KR (1) KR100260573B1 (fi)
CN (1) CN1076605C (fi)
AT (1) ATE182884T1 (fi)
AU (1) AU690241B2 (fi)
CA (1) CA2150287C (fi)
DE (1) DE69511181T2 (fi)
DK (1) DK0690049T3 (fi)
ES (1) ES2137456T3 (fi)
FI (1) FI952721L (fi)
GR (1) GR3031066T3 (fi)
NO (1) NO308993B1 (fi)
NZ (1) NZ272234A (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
MXPA02003756A (es) 1999-10-15 2005-09-08 Sucampo Ag Composicion novedosa y metodo para estabilizar la misma.
WO2001070233A2 (en) 2000-03-24 2001-09-27 Sucampo Ag Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
WO2001076593A2 (en) 2000-04-06 2001-10-18 Sucampo Ag Bile secretion promoting composition a 15-keto prostaglandin
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
WO2003030912A1 (en) 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
WO2005018646A1 (ja) 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
EP1562604B1 (en) * 2002-10-23 2012-01-04 Sucampo AG Prostaglandin compounds for the treatment of obesity
WO2004060377A1 (en) 2002-12-27 2004-07-22 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
AU2006209072B2 (en) * 2005-01-27 2011-02-24 Sucampo Ag Method and composition for treating central nervous system disorders
KR20160120809A (ko) * 2005-03-04 2016-10-18 수캄포 아게 말초 혈관 질환 치료를 위한 방법 및 조성물
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
KR20140069182A (ko) * 2005-04-12 2014-06-09 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용
RU2440144C2 (ru) 2006-01-24 2012-01-20 Р-Тек Уено, Лтд. Фармацевтическая композиция, содержащая бициклическое соединение, и способ стабилизации бициклического соединения
CN104983712A (zh) * 2006-01-24 2015-10-21 株式会社·R-技术上野 软明胶胶囊制剂
EP2735566A1 (en) * 2006-02-07 2014-05-28 R-Tech Ueno, Ltd. Method for preparing prostaglandin derivative
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
AR059636A1 (es) * 2006-02-28 2008-04-16 Sucampo Ag Metodo y composicion para tratar la enfermedad pulmonar obstructiva cronica
US20090062381A1 (en) 2006-03-13 2009-03-05 Ryu Hirata Aqueous composition
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
CA2830626A1 (en) 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia
WO2012144649A1 (en) * 2011-04-19 2012-10-26 Sucampo Ag Method for modulating cytokine activity
TWI540125B (zh) * 2011-07-01 2016-07-01 艾德克 上野股份有限公司 脂肪酸衍生物的製備方法
CN102875586A (zh) * 2011-07-11 2013-01-16 上海天伟生物制药有限公司 一种利马前列素关键中间体的制备方法
CN107903173A (zh) 2011-08-05 2018-04-13 苏坎波公司 治疗精神分裂症的方法
CN103058907B (zh) * 2011-10-21 2016-05-11 武汉启瑞药业有限公司 鲁比前列酮或其中间体的制备方法
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative
US10428566B2 (en) * 2017-04-17 2019-10-01 James G. Arendts Flexible unitary sandwich-like panel overhead door

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306078A (en) * 1979-12-03 1981-12-15 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4374856A (en) 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS62129218A (ja) 1985-12-02 1987-06-11 Teijin Ltd チアプロスタグランジン類を活性成分として含有する肝疾患治療剤
JPH0688966B2 (ja) 1987-01-28 1994-11-09 株式会社アールテック・ウエノ プロスタグランジンｅ類およびそれを含む抗潰瘍剤
CA1323364C (en) 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
DE3873007T2 (de) 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
DD295522A5 (de) * 1989-07-26 1991-11-07 �����@������������������k�� 5-Alkyl-1,3,4-Thiadiazole, Verfahren zu ihrer Herstellung und Verwendung als Schädlingsbekämpfungsmittel
CA2027814C (en) 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
EP0690049A2 (en) 1996-01-03
KR100260573B1 (ko) 2000-07-01
DE69511181D1 (de) 1999-09-09
DE69511181T2 (de) 1999-12-02
NZ272234A (en) 1996-02-27
KR960000230A (ko) 1996-01-25
AU690241B2 (en) 1998-04-23
NO952214D0 (no) 1995-06-02
ES2137456T3 (es) 1999-12-16
ATE182884T1 (de) 1999-08-15
CN1076605C (zh) 2001-12-26
DK0690049T3 (da) 2000-03-06
EP0690049A3 (en) 1997-03-26
US5739161A (en) 1998-04-14
FI952721A0 (fi) 1995-06-02
GR3031066T3 (en) 1999-12-31
CN1126591A (zh) 1996-07-17
NO952214L (no) 1995-12-04
NO308993B1 (no) 2000-11-27
CA2150287C (en) 2004-08-10
CA2150287A1 (en) 1995-12-04
AU2041295A (en) 1995-12-14
EP0690049B1 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
FI952721L (fi) Aine maksa-sappi-sairauksien hoitamiseksi
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
FI972681L (fi) Kynsien sientenvastainen käsittely
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
EE200000164A (et) Inimkeha tasakaalu taastamise aparaat
DK0769017T3 (da) Terapeutiske forbindelser
DE69524138D1 (de) Hautbehandlungsmittel
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
DE69529295D1 (de) Chemische proteindenaturierungsbehandlung
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DE69840432D1 (de) Arzneimittel zur behandlung der augen
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
UA25833C2 (uk) Засіб для лікуваhhя мелаhомобластом